Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. | Zendy

Sean Smart | Zendy; Stephen G. Sawada | Zendy; Thomas Ryan | Zendy; Douglas S. Segar | Zendy; Lawrence Atherton | Zendy; Kenneth E. Berkovitz | Zendy; Patrick D.V. Bourdillon | Zendy; Harvey Feigenbaum | Zendy

Open Access

Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction.

Author(s) -

Sean Smart,

Stephen G. Sawada,

Thomas Ryan,

Douglas S. Segar,

Lawrence Atherton,

Kenneth E. Berkovitz,

Patrick D.V. Bourdillon,

Harvey Feigenbaum

Publication year - 1993

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.88.2.405

Subject(s) - dobutamine , medicine , cardiology , myocardial infarction , creatine kinase , hemodynamics

Dysfunction after thrombolytic therapy of acute myocardial infarction (MI) may be reversible. Early after myocardial infarction, both reversible and irreversible injury may be manifested by regional wall motion abnormalities. Improved wall thickening during dobutamine infusion (dobutamine-responsive wall motion) may accurately identify reversibly injured segments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research